Compare JD.Com Inc (JD) vs Oscar Health Inc (OSCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
JD.Com Inc vs Oscar Health Inc — how do they compare? JD.Com Inc trades at $30.13 (market cap $41.80B), while Oscar Health Inc trades at $30.74 (market cap $8.92B). The key difference: JD.Com Inc is far larger — about 4.7× Oscar Health Inc's market cap, and JD.Com Inc pays a 3.27% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals.
| JD | OSCR | |
|---|---|---|
Market Cap | $41.80B | $8.92B |
Sector | Consumer Cyclical | Health |
52-Week High | $36.17 | $32.18 |
52-Week Low | $25.19 | $10.85 |
Enterprise Value | $27.96B | $4.55B |
Dividend Yield | 3.27% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
JD.com trades at $30.43, up 2.73% with strong technical momentum and bullish analyst sentiment. The stock shows consistent earnings beats with Q1 2026 EPS of $0.74 exceeding expectations. Revenue reached $1.31 trillion in 2025, though net margins compressed to 1.05%. Technical indicators signal bullish momentum with the stock trading near key resistance levels.
Wall Street maintains strong bullish outlook with 69.6% buy ratings and $39.50 consensus target, representing 30% upside potential. Key risks include margin pressure, regulatory investigations, and Chinese market volatility. The company's aggressive buyback program and AI investments provide fundamental support despite competitive pressures.
Oscar Health (OSCR) trades at $29.60, up 1.72% with mixed technical signals showing neutral overall momentum. The company reported strong Q1 2026 earnings beat but faces profitability challenges with negative margins. Revenue growth from $11.7B in 2025 to projected $13.3B in 2026 indicates expansion, while cash flow trends show operational improvement. Analyst consensus is divided with 27% buy ratings against a $24.67 price target below current levels.
The stock presents growth potential through revenue expansion and cash flow generation, but profitability concerns and negative ROE pose significant risks. Current valuation at 0.61 P/S suggests reasonable pricing for growth, though execution on margin improvement remains critical for sustained upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About JD.Com Inc
JD.com is China's second-largest e-commerce company after Alibaba in terms of gross merchandise volume, offering a wide selection of authentic products at competitive prices, with speedy and reliable delivery. The company has built its own nationwide fulfilment infrastructure and last-mile delivery network, staffed by its own employees, which supports both its online direct sales, its online marketplace and omnichannel businesses.
Read more on JD →About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →
